Investigating Alzheimer's Disease and Related Dementias in American Samoa
Official title: Alzheimer's Disease and Related Dementias (ADRD) prevalence in American Samoa
Funded at American Samoa Community Cancer Coalitio · NIH-10523978 · Data updated 2026-11-12
This study is looking at how common Alzheimer's disease and related dementias are among older adults in American Samoa, with the goal of helping local communities get better support and care for those affected.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | American Samoa Community Cancer Coalitio NIH-funded |
| Lab location | 1 site (Pago Pago, United States) |
| Project start | September 30, 2022 |
| Project end | August 31, 2025 |
| Funding year | 2022 |
| Award (this year) | $6,186,533 |
| NIH project number | 1RF1AG075904-01A1 |
| Project ID | NIH-10523978 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include older adults in American Samoa, particularly those over the age of 50, who may be experiencing cognitive decline or are at risk for ADRD.
✕Less likely to help
Patients who are younger than 50 or do not reside in American Samoa may not receive direct benefits from this research.
What this research studies
This research focuses on understanding the prevalence of Alzheimer's disease and related dementias (ADRD) among the population of American Samoa, particularly among older adults. The study aims to assess the impact of ADRD on indigenous communities, which are facing increasing rates of cognitive impairment. By gathering data on the incidence and risk factors associated with ADRD, the research seeks to enhance healthcare readiness and improve support systems for patients and caregivers in these communities. The methodology includes community engagement and culturally sensitive approaches to ensure accurate data collection and understanding of the local context.
Why it matters
Potential benefit: If successful, this research could lead to improved healthcare strategies and resources for managing Alzheimer's disease and related dementias in American Samoa.
How similar studies have gone: While there is a growing body of research on ADRD in various populations, this specific investigation into the prevalence within the Samoan population is novel and has not been previously studied.
Where this research is happening
-
American Samoa Community Cancer Coalitio
Pago Pago, United States Active
Researchers
- Principal investigator: Tofaeono, Vaatausili T — American Samoa Community Cancer Coalitio
- Study coordinator: Tofaeono, Vaatausili T
Related research
Other NIH-funded projects on the same topics.
-
Understanding how brain activity changes may drive Alzheimer’s disease progression in a mouse model
Researchers are testing how changes in brain signals and protein cleanup processes affect the development of Alzheimer’s disease in mice.
-
Thiamine-boosting therapy for Alzheimer’s: understanding how benfotiamine may reduce harmful AGE in DP patients
A medication-based approach using high-dose vitamin B1 (benfotiamine) is studied to help people with Alzheimer's by reducing harmful sugar-related molecules.
-
Non-invasive tears biomarker for early Alzheimer's in LMICs
A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.
-
Turning APOE4 into protective APOE2 or APOE3Christchurch to help with Alzheimer’s
A patient-facing explanation of a treatment idea that aims to change a genetic risk factor for Alzheimer's disease in the brain.
-
Telomerase in Alzheimer’s Disease: how aging biology could influence memory and brain health
Researchers are exploring a new brain-aging mechanism linked to telomerase, with potential to slow or modify Alzheimer’s disease in people and improve cognitive function.
-
Biomarkers of Alzheimer’s Disease: Sensory, Motor, and Cognitive Clues
Researchers are testing simple sensory and movement tasks to find early signs of Alzheimer’s disease so they can diagnose and treat people sooner.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.